Bruker Corporation

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-09-12 pm EDT 5-day change 1st Jan Change
64.73 USD +1.16% Intraday chart for Bruker Corporation -0.95% -11.91%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Transcript : Bruker Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-06-2024 10:00 AM
Transcript : Bruker Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM
Bruker Announces Successful Installation of 1.2 GHz Avance NMR Spectrometer at the Korea Basic Science Institute CI
Bruker Keeps Quarterly Dividend at $0.05 a Share, Payable Sept. 16 to Stockholders of Record Sept. 2 MT
Bruker Corporation Announces Quarterly Cash Dividend, Payable on September 16, 2024 CI
Bruker Acquires Minority Stake in NovAliX MT
Philip Ma Resigns from Board of Bruker Corporation CI
Bruker Corporation and NovAliX Collaborate Strategically to Develop Novel Drug Discovery Technologies and Methods CI
NovAliX SAS announced that it has received funding from Bruker Corporation CI
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday MT
Transcript : Bruker Corporation, Q2 2024 Earnings Call, Aug 06, 2024
Bruker Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised MT
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q2 Revenue $800.7M, vs. Street Est of $797.8M MT
Earnings Flash (BRKR) BRUKER CORPORATION Reports Q2 EPS $0.52, vs. Street Est of $0.51 MT
Bruker Corporation Updates Financial Guidance for the Full Year of 2024 CI
Bruker Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Certain Common Stock of Bruker Corporation are subject to a Lock-Up Agreement Ending on 29-JUL-2024. CI
Certain Stock Options of Bruker Corporation are subject to a Lock-Up Agreement Ending on 29-JUL-2024. CI
Certain Restricted Stock Units of Bruker Corporation are subject to a Lock-Up Agreement Ending on 29-JUL-2024. CI
Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating MT
Bruker Corporation Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut Für Molekulare Pharmakologie in Berlin CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell Small Cap Comp Value Index CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell Midcap Value Index CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 3000E Value Index CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 2500 Value Index CI
Chart Bruker Corporation
More charts
Logo Bruker Corporation
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.
Employees
9,707
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
64.73USD
Average target price
79.74USD
Spread / Average Target
+23.19%
Consensus
  1. Stock Market
  2. Equities
  3. BRKR Stock
  4. News Bruker Corporation
  5. Earnings Flash (BRKR) BRUKER CORPORATION Posts Q2 Revenue $800.7M, vs. Street Est of $797.8M
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW